US Patent 8044209 Pyrrolydine derivatives as IAP inhibitors
Patent 8044209 was granted and assigned to Novartis on October, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+94 characters)
Article
Patent abstract
The present invention relates to novel IAP inhibitor compounds of: Formula (I).
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Christine Hiu-Tung Chen0
Christopher Sean Straub0
Feng He0
Huangshu Lei0
Leigh Zawel0
Mark G. Charest0
Miao Dai0
Ming Chen0
Run-Ming David Wang0
Zhuoliang Chen0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08044209 Pyrrolydine derivatives as IAP inhibitors US Patent 8044209 Pyrrolydine derivatives as IAP inhibitors
Infobox
Patent Number
08044209
Patent Number
8044209
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08044209 Pyrrolydine derivatives as IAP inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08044209
Date of patent
October 25, 2011
Patent application number
12445435
Date Filed
October 10, 2007
Patent primary examiner
Find more entities like US Patent 8044209 Pyrrolydine derivatives as IAP inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
